 |
|
Poxvirus Potency Uncovered in New Atomic Map
February 04, 2008BIRMINGHAM, Ala. - Scientists at the University of Alabama at Birmingham (UAB) and Saint Louis University used X-ray crystallography to uncover new details about the infectious potency of poxviruses, furthering the understanding of how viral infections can subvert the body's immune system.
Having high-resolution detail of this protein on hand will speed the discovery of new drugs to combat inflammation and immune diseases such as atherosclerosis and rheumatoid arthritis, the researchers said.
The findings are published in the online edition of the journal Proceedings of the National Academy of Sciences and will soon appear in a print edition.
"Now we have a visual blueprint to guide our future studies on interferon-gamma binding protein, which one day may be used to prevent inflammatory disease," said Mark R. Walter, Ph.D., an associate professor in the UAB Department of Microbiology and senior author on the study.
Interferon-gamma binding protein (IFN-y) is notorious for the role it plays in helping poxviruses replicate. Normally when a virus enters the bloodstream, the immune system fights back by producing IFN-y, which tells surrounding cells to fight the infection.
Remarkably, somewhere during the evolution of the poxvirus, it captured an IFN-y gene from its host and incorporated some of the protein structure into its own. As a result poxvirus has a very efficient "blocker" of the IFN-y antiviral response, Walter said.
The new study shows this blocking ability through crystallography, the science of mapping the atomic structure of molecules by looking at their interaction with an X-ray beam.
Poxviruses include many classes of the invasive organism, including smallpox, cowpox and monkeypox. Smallpox in particular has played a tragic role in human history: estimates show it caused between 300 million and 500 million deaths in the 20th Century.
Smallpox was declared officially eradicated in 1979, but other poxviruses remain a health threat.
"The damage that the smallpox virus has done to mankind is horrific and enormous, which is why we think it's so important to understand more about the poxviruses and how they operate," said Mark Buller, Ph.D., professor of microbiology and immunology at the Saint Louis University School of Medicine and a study author. "The more knowledge we have, the better we should be able to cope with other major viruses and diseases in the future."
The research was funded by grants from the National Institutes of Health and the American Heart Association.
University of Alabama at Birmingham
"Now we have a visual blueprint to guide our future studies on interferon-gamma binding protein, which one day may be used to prevent inflammatory disease," said Mark R. Walter, Ph.D., an associate professor in the UAB Department of Microbiology and senior author on the study.
Interferon-gamma binding protein (IFN-y) is notorious for the role it plays in helping poxviruses replicate. Normally when a virus enters the bloodstream, the immune system fights back by producing IFN-y, which tells surrounding cells to fight the infection.
Remarkably, somewhere during the evolution of the poxvirus, it captured an IFN-y gene from its host and incorporated some of the protein structure into its own. As a result poxvirus has a very efficient "blocker" of the IFN-y antiviral response, Walter said.
The new study shows this blocking ability through crystallography, the science of mapping the atomic structure of molecules by looking at their interaction with an X-ray beam.
Poxviruses include many classes of the invasive organism, including smallpox, cowpox and monkeypox. Smallpox in particular has played a tragic role in human history: estimates show it caused between 300 million and 500 million deaths in the 20th Century.
Smallpox was declared officially eradicated in 1979, but other poxviruses remain a health threat.
"The damage that the smallpox virus has done to mankind is horrific and enormous, which is why we think it's so important to understand more about the poxviruses and how they operate," said Mark Buller, Ph.D., professor of microbiology and immunology at the Saint Louis University School of Medicine and a study author. "The more knowledge we have, the better we should be able to cope with other major viruses and diseases in the future."
The research was funded by grants from the National Institutes of Health and the American Heart Association.
University of Alabama at Birmingham
Poxvirus Current Events and Poxvirus News RSSScientists identify genetic cause of previously undefined primary immune deficiency disease
Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency.
DASNR researchers make breakthrough against poxviruses
Smallpox has a nasty history throughout the world. Caused by poxviruses, smallpox is one of the few disease-causing agents against which the human body's immune system is ineffective in its defense.
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research.
Ugandan monkeys harbor evidence of infection with unknown poxvirus
Researchers report this month that red colobus monkeys in a park in western Uganda have been exposed to an unknown orthopoxvirus, a pathogen related to the viruses that cause smallpox, monkeypox and cowpox.
Poxvirus' ability to hide from the immune system may aid vaccine design
The cowpox virus, a much milder cousin of the deadly smallpox virus, can keep infected host cells from warning the immune system that they have been compromised, researchers at Washington University School of Medicine in St. Louis have found.
How to design a cancer-killing virus
One new way to treat individuals with cancer that is being developed is the use of viruses that infect and kill cancer cells while leaving normal cells unharmed.
New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
Smallpox is older than thought, according to results of a new technique reported in the Sept. 24 issue of the Proceedings of the National Academy of Sciences by researchers from Lawrence Livermore National Laboratory and the Centers for Disease Control (CDC).
Penn researchers determine structure of smallpox virus protein bound to DNA
Researchers at the University of Pennsylvania School of Medicine have determined the structure of an important smallpox virus enzyme and how it binds to DNA.
Novel virus entry mechanism could lead to new drugs against poxviruses
Research published in the Proceedings of the National Academy of Sciences on 11 April describes how the Imperial College London team discovered the mechanism allowing Vaccinia virus to shed its outer lipid membrane and enter cells. The mechanism is unique in virology and paves the way for development of new antiviral drugs.
Protein finding could lead to treatment for inflammatory diseases
A protein that undesirably shields a skin poxvirus from the immune system may become the key ingredient in a new topical treatment for inflammatory diseases.
More Poxvirus Current Events and Poxvirus News Articles
![Squirrel poxvirus: Landscape scale strategies for managing disease threat [An article from: Biological Conservation]](http://ecx.images-amazon.com/images/I/51P1T5EY1VL._SL160_.jpg) |
Squirrel poxvirus: Landscape scale strategies for managing disease threat [An article from: Biological Conservation] by J. Gurnell (Author), S.P. Rushton (Author), P.W.W. Lurz (Author), Sainsbury (Author) This digital document is a journal article from Biological Conservation, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Squirrel poxvirus (SQPV) is a well-documented example of pathogen-mediated competition between an invasive species, the grey squirrel (Sciurus carolinensis), and a native species, the Eurasian red squirrel (Sciurus vulgaris). SQPV causes disease with high mortality in red squirrels but appears non-pathogenic in grey squirrels. Not all populations of introduced grey squirrels carry the virus, notably those in Scotland and Italy, and the rate of red squirrel replacement by grey squirrels is some twenty times... |
 |
Molluscum Contagiosum: Heal Molluscum Treatment 11ml by Healing Natural Oils Take advantage of the gifts nature has to offer, such as the gift of essential oils. The oils we use in our Heal Molluscum treatment, which will eliminate all strains of the Molluscum Contagiosum virus, are the highest quality pure essential oils which are 100% natural and organic at source. Heal Molluscum is specially formulated and no pesticides, herbicides or chemical fertilizers have been used during the growth of the plants from which the oils are extracted. You can use Heal Molluscum on your skin condition safe in the knowledge that it will do the job successfully. In adults, molluscum affects the groin, genital area, thighs and lower abdomen and is often acquired sexually. The infection is found worldwide but especially in those areas with warm, humid climates. Immunodeficiency... |
|
Regulation of expression of poxvirus late genes by Dhavalkumar Dhirajlal Patel (Author) | |
|
Multiplication of ovine poxvirus in sheep fetal kidney cell cultures =: Multiplication du virus de la clavelee sur des cultures de cellules de reins d'agneau foetal by A N'Guira (Author) | |
|
Characterization and classification of a naturally occurring poxvirus of racoons by Elaine Kinney Thomas (Author) | |
 |
Orthopoxviruses Pathogenic for Humans by S.N. Shchelkunov (Contributor), S.S. Marennikova (Contributor), R.W. Moyer (Contributor) Orthopoxviruses Pathogenic for Humans covers those viruses capable of causing disease in man, including monkeypox, smallpox, cowpox, and vaccinia. The coverage of each virus is comprehensive, covering the biology, molecular biology, and ecology of the virus as well as the clinical and epidemiological aspects of these viruses in humans and animals. In addition, this volume highlights developments in genetic engineering that are paving the way for potential therapeutic treatments of these viruses. |
|
Human Monkeypox (Monographs in Virology) by Zdenek Jezek (Author), Frank Fenner (Editor) | |
|
Poxviruses (Current Topics in Microbiology and Immunology) by Richard W. Moyer (Author), P. C. Turner (Author) | |
 |
Poxviruses (Birkhäuser Advances in Infectious Diseases) by Andrew Mercer (Editor), Axel Schmidt (Editor), Olaf Weber (Editor) The recent international alarm at the possible use of smallpox as weapon of bioterror has refocused the attention of the scientific community, public health policy makers and the public on poxviruses. In contrast to the threat posed by some of these viruses, other poxviruses show exciting beneficial potential including their use as valuable tools in biomedical research and in the delivery of vaccines. This monograph provides a comprehensive review of the poxvirus family with a particular emphasis on current developments. It includes the latest insights into poxviral molecular biology, diagnosis, therapy, vaccine development and the beneficial exploitation of these viruses in biomedical research. Each chapter is written by a leader in the field. They present in-depth reviews of all aspects... |
|
Patogennye dlia cheloveka ortopoksvirusy (Russian Edition) by S. S Marennikova (Author) |
| © 2009 BrightSurf.com |